Publications by authors named "Michael Fillitz"

Claim this Profile
C
Clinical evidence for antiglycoprotein IIbIIIa antibody-induced platelet desialylation in primary immune thrombocytopenia.
Theresa Schramm, Jan Zlamal, Jasmin Rast, Justin Oosterlee, Michael Fillitz

J Thromb Haemost· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study.
David J Kuter, Waleed Ghanima, Nichola Cooper, Howard A Liebman, Lei Zhang, Michael Fillitz

Blood· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrinolysis is impaired in patients with primary immune thrombocytopenia.
Theresa Schramm, Jasmin Rast, Dino Mehic, Stéphanie E Reitsma, Claire de Moreuil, Michael Fillitz

J Thromb Haemost· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Adult Patients with Newly Diagnosed or Relapsed Primary Immune Thrombocytopenia in Eastern Austria.
Jasmin Rast, Theresa Schramm, Dino Mehic, Michael Fillitz, Tanja Drexel

Hamostaseologie· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QoL during KTd or KRd induction followed by K maintenance or observation in transplant noneligible patients with newly diagnosed multiple myeloma: Longitudinal and cross-sectional analysis of the randomized AGMT 02 study.
Heinz Ludwig, Thomas Melchardt, Ilvy Schweitzer, Siegfried Sormann, Martin Schreder, Michael Fillitz

EJHaem· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma.
Heinz Ludwig, Thomas Melchardt, Siegfried Sormann, Martin Schreder, Johannes Andel, Michael Fillitz

Am J Hematol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease.
Georg Gelbenegger, Ulrich Jäger, Michael Fillitz, Christian Schörgenhofer, Christian Sillaber

Blood Adv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms.
Daniel Ivanov, Jelena D Milosevic Feenstra, Irina Sadovnik, Harald Herrmann, Barbara Peter, Michael Fillitz

Am J Hematol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet function and soluble P-selectin in patients with primary immune thrombocytopenia.
Dino Mehic, Jennifer Machacek, Theresa Schramm, Lisbeth Buresch, Alexandra Kaider, Michael Fillitz

Thromb Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained sutimlimab response for 3 years in patients with cold agglutinin disease: A phase I, open-label, extension trial.
Georg Gelbenegger, Ulrich Jaeger, Michael Fillitz, Shirley D'Sa, Ronwyn Cartwright

Br J Haematol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical considerations for the management of immune thrombocytopenic purpura.
Michael Fillitz, Barbara Dixer, Felix Keil

Memo· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program.
Georg Gelbenegger, Christian Schoergenhofer, Ulla Derhaschnig, Nina Buchtele, Christian Sillaber, Michael Fillitz

Blood Adv· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial.
Ulrich Jäger, Shirley D'Sa, Christian Schörgenhofer, Johann Bartko, Ulla Derhaschnig, Michael Fillitz

Blood· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone Involvement in Rosai-Dorfman Disease (RDD): a Case Report and Systematic Literature Review.
Birgit A Mosheimer, Bastian Oppl, Shahin Zandieh, Michael Fillitz, Felix Keil

Curr Rheumatol Rep· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)].
Ingrid Pabinger, Günther Gastl, Michael Steurer, Siegfried Sormann, Michael Fillitz

Wien Klin Wochenschr· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does mRNA level of microsomal carnitine palmitoyltransferase predict yield of peripheral blood stem cell apheresis?
Michael Fillitz, Heidrun Karlic, Heinz Tüchler, Johannes Zeibig, Wolfgang Spiegel

Ann Hematol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis